- 'Umbrella' Valve Provides A Potential Alternative To Lung Surgery By : Respiratory News
A new umbrella-like valve may help patients with emphysema breathe easier and may ultimately provide a noninvasive alternative to lung reduction surgery. In a new study presented at CHEST 2006, the 72nd annual international scientific assembly of the American College of Chest Physicians (ACCP), the IBV(TM) Valve, a nonsurgical, investigational device, was shown to be safe and effective for patients with emphysema. - 80% Of Adults With Long-term Lung Disease Do Not Know They Have It By : Respiratory News
Chronic Obstructive Pulmonary Disease (COPD) which includes chronic bronchitis and emphysema goes undiagnosed in 80 per cent of people who suffer from it according to a new report by Cancer Research UK published online today in Thorax. - 9/11 Rescuers Had More Lung Problems Than First Thought By : Respiratory News
The number of rescuers who developed lung problems during and after the terrorist attacks on the World Trade Center, New York, is much higher than previously thought, according to a new report by Mount Sinai Medical Center, New York City. 69% of rescuers who were examined said they experienced respiratory problems during the time they responded to the attack. 59% of them still had symptoms two-and-a-half years later. - Adams Respiratory Therapeutics Completes Repurchase Of Manufacturing Assets And Operations By : Medical News
Adams Respiratory Therapeutics, Inc. (Nasdaq: ARxT) today announced that it has completed its previously announced repurchase of the manufacturing assets and operations in Fort Worth, Texas, from Cardinal Health. - Advair(R) HFA Inhalation Aerosol Now Available By : Respiratory News
Advair HFA Inhalation Aerosol, a new formulation combining fluticasone propionate and salmeterol in a metered-dose inhaler (MDI) delivery device, is now available in pharmacies nationwide. Advair(R), a medicine used in the treatment of asthma, became available in 2001 as a dry-powdered inhaler known as Advair Diskus (fluticasone propionate and salmeterol). - Air Quality Group Brings Relief To Public By : Respiratory News
People with asthma or other respiratory problems can breathe a sigh of relief thanks to University of Houston professors who have recently unveiled a forecasting system that provides air quality data on ozone conditions. - Airway Inflamation Caused By Trauma Of Chronic Cough By : Medical News
New findings suggest that airway trauma, caused by the act of coughing, may cause inflammation associated with chronic cough. Researchers from the University of Massachusetts Medical School conducted a cross-sectional, controlled study of 24 respiratory patients with chronic cough. The patients were split into four groups: intrapulmonary diseases, extrapulmonary diseases, unexplained cough, and four additional volunteers provided the nonsmoking, asymptomatic controls. - American Lung Association Collaborates With Leading Vaccine Manufacturer On New Initiative By : Medical News
The American Lung Association announced today it will collaborate on a new, far-reaching influenza public awareness initiative with sanofi pasteur, the nation's leading influenza vaccine manufacturer. As the nation's oldest voluntary health organization, the Lung Association will expand its annual influenza awareness efforts to educate the public about influenza and the need for vaccination through support and resources from sanofi pasteur. - American Lung Association Launches Information And Access Program By : Respiratory News
As a fast-relief inhaler used by millions of Americans with asthma is phased-out for environmental reasons, the American Lung Association today launched an educational and access initiative. - American Thoracic Society President Calls New EPA Soot Standards ‘Demonstrably Unhealthy' By : Respiratory News
John E. Heffner, M.D., president of the American Thoracic Society, today called new standards issued by the Environmental Protection Agency for fine particulate matter pollution, more commonly known as soot, "inadequate and demonstrably unhealthy." - ANTI INFLAMMATORY DRUGS CAN BE ALSO GOOD FOR ASTHMATIC PERSONS By : cathy
The article is about asthma and its causes, symptoms, and treatment which include allergen management and the use of anti-inflammatory drugs.. - Antibiotics Unnecessarily Prescribed For Acute Bronchitis By : Respiratory News
Antibiotics are routinely prescribed unnecessarily for acute bronchitis, according to Virginia Commonwealth University findings published in the 15-Nov-2006 issue of the New England Journal of Medicine. - Approved Asthma Therapy SYMBICORT Improves Lung Function Safely And Effectively By : Respiratory News
Newly presented data indicate that treatment with SYMBICORT(R) (budesonide/formoterol fumarate dihydrate) inhalation aerosol results in significantly greater improvements in lung function, and a lower risk of asthma worsening episodes, compared to budesonide and/or formoterol used alone. In addition, data also showed that SYMBICORT was generally well-tolerated, with an adverse event profile similar to that of its individual components. - Asthma And Soot From Diesel Trucks In Bronx Linked By : Respiratory News
Soot particles spewing from the exhaust of diesel trucks constitute a major contributor to the alarmingly high rates of asthma symptoms among school-aged children in the South Bronx, according to the results of a five-year study by researchers at New York University's School of Medicine and Robert F. Wagner Graduate School of Public Service. - Asthma Causes Symptoms Information with Treatment By : Juliet Cohen
Asthma occurs when the main air passages of your lungs, the bronchial tubes, become inflamed. This airway narrowing causes symptoms such as wheezing , shortness of breath , chest tightness, and coughing , which respond to bronchodilators. - Asthma Emergencies Expected To Spike As Students Return To School By : Respiratory News
Like clockwork, asthma attacks and hospitalizations among children returning to school peak 18 days after Labor Day but parents are largely unprepared for the respiratory assault, says a new survey from the American Lung Association. - Asthma Information By : Juliet Cohen
Asthma is a chronic disease that affects your airways. The muscles of the bronchial walls tighten, and cells in the lungs produce extra mucus further narrowing your airways. This can cause minor wheezing to severe difficulty in breathing. - Asthma Linked To Increased Risk For Sleep Apnea In Young Women By Study By : Respiratory News
Researchers from the University of Cincinnati (UC) and Cincinnati Children's Hospital Medical Center (CCHMC) have found that young women with asthma are twice as likely to have symptoms of obstructive sleep apnea--a condition that often goes undetected in women--compared with those who do not have asthma. - Asthma May Be Overdiagnosed In Obese Patients By : Respiratory News
A new study reveals that, despite lack of evidence, obese patients are often diagnosed with asthma. Researchers at Newark Beth Israel Medical Center in New Jersey studied 20 patients, all of whom had a diagnosis of asthma, but none of whom exhibited any spirometric evidence of airway obstruction. - Asthma More Prevalent In Wheezy, Allergic Children By : Respiratory News
Children who become sensitive to allergens, such as cat hair, and suffer from wheezing in their first three years of life are prone to developing asthma*, according to an Article in this week's issue of The Lancet. - Asthma Treatment and Prevention By : Juliet Cohen
Asthma is a chronic disease that affects your airways. The airways are the tubes that carry air in and out of your lungs. The muscles of the bronchial walls tighten, and cells in the lungs produce extra mucus further narrowing your airways - Asthma: Learn how to measure your breathing level using - The Measurement Pause By : James Hooper
Asthma is a terrible disease that has victims from all over the world and nobody seems to be immune from this disease. In my article I am going to outline the following breathing test that will give you a simple measurement of your breathing level. It is easy to do, and can be done by anyone over the age of 4 years. - Astrazeneca Receives Japan Approval For CFC-free Corticosteroid Inhaler For Paediatric Asthma By : Medical News
Astrazeneca announced on July 27 that it had received approval for its Pulmicort Turbuhaler, an inhaler for pediatric asthma infants from 6 months to under 5 years old, frrom the Japanese Ministry of Health, Labor and Welfare. - Biosignal New Program To Develop Infection Drug Candidates By : Respiratory News
Biosignal Ltd (ASX: BOS) has engaged US company Bioduro Inc to further develop two different classes of therapeutic compounds based on Biosignal's novel technology. Biosignal's therapeutic target markets are respiratory infections and urinary tract infections. - BioWa, Inc. Begins Phase 1 Clinical Trial In Asthma By : Respiratory News
BioWa, Inc. announced today that it is beginning its Phase 1 clinical trial to evaluate the safety and tolerability of BIW-8405, BioWa's anti-IL-5 receptor monoclonal antibody (Mab). The Mab is being developed for the treatment of asthma. - Breathe Easier! Family Guide To Winter Allergies - Ten Tips On Improving Life In The Winter By : Medical News
Spring and summer are not the only seasons that bring misery to those with allergies. - Cases Of Tuberculosis Rise Steeply During 2005, England, Wales And Northern Ireland By : Respiratory News
Cases of Tuberculosis (TB) in England, Wales and Northern Ireland have increased by 10.8% from 7,321 cases reported in 2004 to 8,113 in 2005 according to new figures released today by the Health Protection Agency. - Causes and Ayurvedic Cures for Asthma By : Dev_Sri
Asthma is a respiratory disease characterized by difficulty in breathing. It is a chronic disease affecting lungs, characterized by inflammation in respiratory tract. The most visible signs are coughing with difficulty, tightness at chest and general difficulty breathing. - Chemical In Many Air Fresheners May Reduce Lung Function By : Medical News
New research shows that a chemical compound found in many air fresheners, toilet bowl cleaners, mothballs and other deodorizing products, may be harmful to the lungs. Human population studies at the National Institute of Environmental Health Sciences (NIEHS), a part of the National Institutes of Health, found that exposure to a volatile organic compound (VOC), called 1,4 dichlorobenzene (1,4 DCB) may cause modest reductions in lung function. - Cincinnnati Scientists Pursue New Target For Asthma Treatment By : Respiratory News
Cincinnati scientists have found further evidence that certain defensive white cells in the body cause or play a major role in the symptoms experienced by asthma patients. - City Kids With Asthma Lose Out On Preventive Treatment By : Respiratory News
A new study by specialists at the Johns Hopkins Children's Center and elsewhere suggests that only one in five inner-city children with chronic asthma gets enough medicine to control dangerous flare-ups of the disease. - Connexin Conducts Cell-to-cell Conversations In The Inflamed Lung By : Medical News
Severe lung inflammation, which can cause acute lung injury in cases of sepsis and infection, is associated with the accumulation in the lung and surrounding blood vessels of fluid, cells, and cellular debris. The deposition of inflammatory exudates spreads rapidly and can soon involve the entire lung or both lungs. The mechanisms underlying the spread of inflammation across the vast vascular network in the lung has remained unexplained, until now. - COPD - Statement Of Dr. Norman H. Edelman, Chief Medical Officer, American Lung Association By : Respiratory News
COPD is the fourth leading cause of death in America, claiming the lives of 122,283 Americans in 2003. It is a term used to describe the obstruction of airflow associated primarily with emphysema and chronic bronchitis. While COPD cannot be cured, it can be treated. - COPD Patients With Acid Reflux Twice As Likely To Experience Exacerbations By : Respiratory News
A new study shows an association between acid reflux symptoms and chronic obstructive pulmonary disease (COPD) exacerbations. Using a questionnaire-based, cross-sectional survey, researchers from the University of Florida, Jacksonville, investigated the prevalence and effect of acid reflux symptoms, formally known as gastroesophageal reflux disease (GERD), on the rate of exacerbations in 86 patients with COPD (57 percent men, mean age 67.5 years). - COPD Progression More Rapid In Smokers By : Respiratory News
Patients with COPD, who continue to smoke, have the worst disease prognosis, according to a new study. Researchers from Illinois and Massachusetts collected the pyrometer data of 538 participants from the Framingham Heart Study. - Critical Therapeutics Files Controlled Release Formulation Of Zileuton By : Medical News
SkyePharma PLC (Nasdaq: SKYE; LSE: SKP) announces that its partner Critical Therapeutics Inc ("CTI", Nasdaq: CRTX) has submitted a New Drug Application to the US Food & Drug Administration for a controlled-release formulation of the oral anti- inflammatory drug zileuton for asthma in adults and children aged 12 years or older. The new formulation only needs to be taken twice a day whereas Zyflo(R), the currently marketed version of zileuton, has the drawback of requiring dosing four times a day. - Detailed Information on Asthma By : Juliet Cohen
Asthma is a serious, sometimes fatal respiratory disease. Asthma is a disease that affects the respiratory tract - small tubes that carry air in and out of lungs. Respiratory problems can be caused by different conditions. Signs of an episode asthma include wheezing, rapid breathing (tachypnea), chronic diseases, expiration, a fast heart rate (tachycardia), rhonchous lung sounds (audible through a stethoscope), and on inflation of the chest. - Detection Of Abnormal Airways Improved Use Of Helical MDCT By : Respiratory News
Use of helical high-resolution multi-detector CT (MDCT) with one millimeter collimation proves to be better than conventional high-resolution CT (HRCT) in showing the presence and extent of bronchiectasis (abnormal enlargement of the respiratory passages within the lungs), according to a study conducted by Vancouver General Hospital's department of radiology in Vancouver, BC, Canada. - Detection Of Latent Tuberculosis Aided By New Blood Tests By : Respiratory News
Thanks to the availability of two new blood tests called T-SPOT.TB and QuantiFERON-TB Gold, physicians around the world can better detect latent tuberculosis (TB) infection. The tests, which reduce the number of false positive and negative results inherent to the old tuberculin skin test, are just two examples of clinical advances in TB control that could potentially eliminate the disease during the 21st century. - Diabetes Increases Asthma Prevalence By : Respiratory News
A new study reveals that the prevalence of asthma is significantly higher in patients with type II diabetes mellitus (DM), independent of other comorbid conditions. California researchers reviewed data from 293,124 patients with DM and 552,623 patients with hypertension but no DM (control group). - Diaphragm Atrophy Occurs Within Two Weeks Of Mechanical Ventilation By : Respiratory News
Ventilated, acutely critically ill patients may experience significant diaphragmatic atrophy within the first two weeks of mechanical ventilation, according to a new Mt. Sinai School of Medicine study. - Drug Combo Improves Survival In Patients With COPD By : Respiratory News
A combination of two common medications may help patients with chronic obstructive pulmonary disease (COPD) live longer. New research presented at CHEST 2006, the 72nd annual international scientific assembly of the American College of Chest Physicians (ACCP), shows that when used in combination, inhaled salmeterol (SAL) and fluticasone propionate (FP) reduced the risk of dying by up to 17.5 percent in patients with COPD. Currently. - Drug Resistant Tuberculosis Strains Worry Europeans By : Respiratory News
European Union (EU) countries are becoming increasingly alarmed by drug resistant strains of tuberculosis (TB) which, according to the Red Cross, pose the most serious TB threat since Word War II. According to the World Health Organization (WHO), the threat is already reaching the borders of the EU. - Ekips Announces Interim Report On World's Largest Breath Analysis Project For Laser-Based Diagnostic By : Respiratory News
Patrick McCann, Ph.D., founder and president of Ekips Technologies, announces today the company has reported the first half results of the world's largest research effort related to lasers in breath analysis and diagnosis. - Elderly Lung Transplant Patients More Likely To Survive By : Respiratory News
Who is too old to receive a lung transplant? - Experts And Policymakers Demand Changes To The Current Approach To Asthma Management By : Respiratory News
Clinical and regulatory changes must be made to asthma management to ensure it reflects current scientific understanding of the disease, and the needs of patients, say asthma experts. These conclusions form part of the 'Brussels Declaration', defining changes that need to be made in order to improve outcomes for asthma patients. - Experts And Policymakers Demand Changes To The Current Approach To Asthma Management By : Respiratory News
Clinical and regulatory changes must be made to asthma management to ensure it reflects current scientific understanding of the disease, and the needs of patients, say asthma experts. These conclusions form part of the 'Brussels Declaration', defining changes that need to be made in order to improve outcomes for asthma patients. - Exposure To Environmental Tobacco Smoke Causes Respiratory Symptoms In Healthy Adults By : Respiratory News
aOver time, inhaling environmental tobacco smoke (ETS)--a process often called "passive smoking"--can cause otherwise healthy adults to develop chronic respiratory symptoms. - FDA Warns Three Pharmacies About Making Own Versions Of Brand-Name Drugs For Asthma By : Medical News
FDA in a press release Thursday said that it has warned three large pharmacies that they are in violation of federal law by producing and distributing unapproved "compounded" inhalation drugs, USA Today reports. Pharmacies are typically permitted to "compound," or formulate, drugs only when they have legitimate prescriptions for patients who need products not produced by commercial manufacturers. - First Asthma Census Highlights Lack Of Control Of Condition, UK By : Respiratory News
An Asthma UK census has revealed that only 4% of those people questioned have their asthma under control. - Flu - A Shot In The Arm Could Save Your Child's Life By : Medical News
Flu season is approaching again, and parents should know that fall is the time to have your children immunized. This is especially important for children with asthma and other high-risk medical problems. - For Respiratory Health, Prevention And Testing Early Are Key By : Respiratory News
Did you know you could have a serious lung disease, yet show no symptoms? The facts are respiratory disease is the 4th leading cause of death in the U.S., and countless people suffer from a breathing disorder and don't know it. - General Pulmonary: Swallowing, Chronic Cough And Surgical Glue By : Respiratory News
Difficulty Swallowing May Contribute to Treatment Failure in Chronic Cough - Genetic Disorder Linked To Rapid Lung Function Decline In Some World Trade Center Rescue Workers By : Respiratory News
A rare genetic disorder known as alpha-1 antitrypsin (A1AT) deficiency may predispose patients to developing lung conditions, but a new rapid-response test could help identify patients with the deficiency before significant lung damage has occurred. - Giving The Right Number Of "\sighs" Prevents Ventilation Induced Lung Injury By : Medical News
Ventilation therapy burst into the public consciousness more than 60 years ago with the "iron lung" and the polio epidemic. Mechanical ventilation has come a long way since then and is used today with patients who cannot breathe on their own because of trauma, lung injuries and chronic lung disease. - Glade(R) Products Do Not Contain Ingredient Reported By The U.S. National Institutes Of Health By : Medical News
Today SC Johnson stated once again that none of its products contain the chemical ingredient 1,4 dichlorobenzene (1,4 DCB). This chemical has been the subject of a study done by the National Institute of Environmental Health Sciences (NIEHS). The study, published in the August 2006 issue of the journal Environmental Health Perspectives suggested exposure to 1,4 DCB (also known as paradichlorobenzene or pDCB) may cause modest reductions in lung function. - GlaxoSmithKline Welcomes New GINA Guidelines For Asthma Management And Prevention By : Respiratory News
GlaxoSmithKline (GSK) today welcomes new guidelines for Asthma Management and Prevention released today from The Global Initiative for Asthma (GINA). The guidelines emphasise that the overall aim of asthma treatment is to achieve and maintain long-term control of the disease and introduce a new classification of asthma based on levels of control1. Recommended treatment action is then based on the patient's level of control.1 - Gluten Intolerance Quadruples Susceptibility To Tuberculosis By : Respiratory News
People who are gluten intolerant run four times the risk of developing active tuberculosis (TB) infection, suggests research published ahead of print in Thorax. - Growing Warnings About Asthma Drug Added To By Experts By : Respiratory News
University of Iowa asthma experts are trying to ensure that an asthma drug combination is prescribed only when truly necessary.
The long-acting asthma drug salmeterol used in combination with an inhaled corticosteroid can dangerously worsen asthma for a small subgroup of people with the condition. - Home Nebulizer Misuse May Contribute To Death By : Respiratory News
A new study suggests that the misuse of home nebulizers may have been a contributing cause of patient deaths in Michigan. All asthma-related deaths in Michigan, between 2002 to 2004, in patients 2- to 34-years-old, were identified. In total, 86 deaths occurred, 38 of which were children. - Hope Offered To Patients With Lung And Joint Disease By Key Study By : Respiratory News
People who suffer from inflammatory conditions such as chronic diseases of the lung, joints and other organs could benefit from a new discovery by scientists at the University of Edinburgh. A new study in Nature Medicine journal shows that certain drugs, already being tested as cancer treatments, can dramatically reduce tissue inflammation. - Hospitalization Varies Among Young Minorities With Asthma By : Medical News
A new, cross-sectional study reveals that health-care utilization of Puerto Rican and African-American children, residing in the same community, are disproportionate. Researchers from New England screened 6,554 children for asthma using a parental survey. Medicaid and Supplementary Children's Health Insurance Plan provided health-care utilization data that were collected for each child for the 12 preceding months. - Inhaled Nitric Oxide Reduces Lung Disease In Premature Babies By : Medical News
Delivering nitric oxide to the lungs of premature, very-low-birth-weight infants during their second week of life improves their chances of surviving without chronic lung disease, according to a national study of nearly 600 babies. For thousands of infants born prematurely each year in the United States, the treatment may help them to breathe easier - and shorten their hospital stay. - Inmates Show Lack Of Effort In Pulmonary Function Tests By : Respiratory News
Incarcerated patients (ICP) are more likely to exhibit inadequate patient effort in pulmonary function tests (PFT), when compared with unincarcerated controls, according to a new study. - Insurance Data Show High Costs Of Persistent Asthma By : Respiratory News
Patients with persistent asthma incur high medical costs as well as indirect costs for employers, reports a study in the August Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine (ACOEM). - Interferon Gamma Therapy May Be An Important Advance In Idiopathic Pulmonary Fibrosis Patients By : Respiratory News
Idiopathic pulmonary fibrosis (IPF), the most common and lethal form of lung scarring, has an outcome similar to that of lung cancer, with average survival of less than three years from diagnosis. - JCI Publishes Preclinical Study Evaluating Potential Ability Of CVT-6883 By : Medical News
CV Therapeutics, Inc. (Nasdaq: CVTX) announced today that the Journal of Clinical Investigation (JCI) has published a preclinical study suggesting that CVT-6883 significantly reduced elevated markers of inflammation, fibrosis and pulmonary injury in two separate in vivo models. - Job Safety Education Can Reduce Respiratory Symptoms By : Quit Smoking News
Professional cleaners who do not receive or understand workplace safety education are more likely to experience occupational asthma, according to a new study. Canadian researches preformed a work-place safety survey of 566 professional cleaners. - Key To Acute Lung Injury Lies In Ang2 Protein By : Respiratory News
Acute lung injury caused by cell death, high and potentially toxic concentrations of oxygen (hyperoxia), and the resulting excess fluid in the lungs (pulmonary edema), may be controlled by modulating levels of the angiopoietin2 (Ang2) protein, researchers at Yale School of Medicine report in the November 5 online issue of Nature Medicine. - Large Community Spirometry Screening For COPD Proves Successful By : Respiratory News
Large scale, community spiromety screening for chronic obstructive pulmonary disease (COPD), can be successfully performed in non-traditional settings, according to a new study. The research, presented at CHEST 2006, the 72nd annual international scientific assembly of the American College of Chest Physicians (ACCP), also demonstrates that community spirometry screenings can identify a large proportion of subjects with significant impairment. - Large Community Spirometry Screening Proves Successful By : Respiratory News
Large scale, community spiromety screening for chronic obstructive pulmonary disease (COPD), can be successfully performed in non-traditional settings, according to a new study. The research, presented at CHEST 2006, the 72nd annual international scientific assembly of the American College of Chest Physicians (ACCP), also demonstrates that community spirometry screenings can identify a large proportion of subjects with significant impairment. - Large Untapped Global Market Exists For Improved TB Tests By : Respiratory News
A significant and largely untapped global market exists for more effective and affordable tests to diagnose tuberculosis in low and middle income countries, where most TB cases today occur. - LR4 Performs A Balancing Act In The Lungs By : Respiratory News
Emphysema is a chronic lung disease that causes severe shortness of breath. It is characterized by a gradual loss of lung elasticity and irreversible airspace enlargement. Maintaining the correct balance of oxidants and antioxidants is crucial to maintaining the structure of the lungs, but exactly how this is done is not well defined. - Lung DCs Legitimate Targets For Treating Asthma By : Respiratory News
Allergic asthma is caused by an unwanted immune response known as a Th2 cell response. Most treatments for asthma currently target this Th2 cell response and its downstream effects. However, immune cells known as dendritic cells (DCs) are crucial activators of all T cell responses, including the Th2 cell response in asthma, so therapies that target DC function in the airways might represent a new way to treat individuals with allergic asthma. - Lungs Try To Repair Damaged Elastic Fibers By : Respiratory News
The lungs of patients suffering chronic obstructive pulmonary disease (COPD) attempt to repair damaged elastic fibers, a new finding that contradicts the conventional wisdom on the capabilities of the adult lung. - MAP Pharmaceuticals Initiates Phase 2 Clinical Trial In Pediatric And Adolescent Patients By : Medical News
MAP Pharmaceuticals today announced the initiation and first patient dosing of a Phase 2 clinical trial evaluating MAP0010. MAP0010 is a proprietary nebulized formulation of budesonide for the inhalation treatment of asthma in both pediatric and adult populations. This novel approach to therapy is intended to provide the same efficacy as the currently marketed nebulizer product, but with a lower dose delivered in less time. - Medicines Regulator Informs Healthcare Professionals About Prescribing UK By : Medical News
The Chief Executive of the Medicines and Healthcare products Regulatory Agency (MHRA) has written to healthcare professionals today about the prescribing of CFC-free inhalers to treat asthma. There are two CFC-free inhalers available on the UK market which contain the active substance beclometasone dipropionate, called Clenil Modulite and Qvar. - MediciNova Announces The Initiation Of The Phase III Clinical Program For MN-001, A Novel Oral Treat By : Respiratory News
MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Hercules Market of the Osaka Securities Exchange (Code Number: 4875), today announced the initiation of its Phase III clinical program to determine the safety and efficacy of its novel oral treatment for bronchial asthma (MN-001) in asthma patients - Mold And Bacteria Levels In New Orleans Homes Warrant Use Of Strong Respiratory Protection By : Respiratory News
In a study assessing flood clean-up procedures in New Orleans following Hurricane Katrina, a team of scientists led by researchers at Columbia University's Mailman School of Public Health, report that household levels of mold and bacterial endotoxins in three single-family homes were so considerable that they equaled or surpassed those in waste- water treatment plants, cotton mills, and agricultural environments. - Monitoring Study Will Complement Previously Announced Clinical Development Program By : Medical News
Xenomics, Inc. (OTC Bulletin Board: XNOM; FWB:XE7), the source of next-generation medical DNA diagnostic technologies, today announced patient enrollment has begun at Italy's National Institute for Infectious Diseases "Lazzaro Spallanzani" for a tuberculosis monitoring study using Xenomics' proprietary Transrenal DNA (Tr-DNA) diagnostic technology - Monoclonal Antibody Reduces Exacerbations In Asthmatics By : Respiratory News
Patients with symptomatic moderate asthma who were treated with anti-tumor necrosis factor alpha, an anti-inflammatory monoclonal antibody, experienced significantly fewer disease exacerbations than individuals taking a placebo. - Mortality Rate Is Twice As High In Patients With Pneumonia Caused By Highly Resistant Bacteria By : Medical News
Patients suffering from hospital-acquired pneumonia caused by a type of bacteria that is highly resistant to virtually all antibiotics are twice as likely to die as patients infected with other, less resistant bacteria. A study published today in the journal Critical Care shows for the first time that the highly resistant, metallo-beta-lactamase-producing Pseudomonas aeruginosa is associated with a much higher mortality rate than other types of the bacteria in patients. - Mothers' Vitamin E Deficiency Linked To Asthma In Kids By : Respiratory News
Children whose mothers had low levels of vitamin E while they were pregnant are five times more likely to develop asthma or wheezing than children's whose mothers had high levels of the vitamin, say scientists from the University of Aberdeen, Scotland. The researchers say it is important for pregnant mothers to make sure their vitamin E levels are good. - Mutual Recognition Procedure Completed For Symbicort® Maintenance And Reliever Therapy By : Respiratory News
AstraZeneca today announced that it has successfully completed the European Union Mutual Recognition Procedure (MRP) for Symbicort® Maintenance And Reliever Therapy (Symbicort SMART®). This new asthma treatment approach allows patients to use just one inhaler for both maintenance and relief of asthma symptoms. - Mutual Recognition Procedure Completed For Symbicort® Maintenance And Reliever Therapy By : Respiratory News
AstraZeneca today announced that it has successfully completed the European Union Mutual Recognition Procedure (MRP) for Symbicort® Maintenance And Reliever Therapy (Symbicort SMART®). This new asthma treatment approach allows patients to use just one inhaler for both maintenance and relief of asthma symptoms. - Mysterious Viruses That Caused New York Respiratory Illnesses In 2004 Identified By New Tool By : Respiratory News
In 2004, scores of New Yorkers with respiratory infections had respiratory swabs taken and sent to the New York State Department of Health to identify the exact cause of their illnesses, but in many cases no diagnoses could be made because the swabs tested negative with existing assays for known respiratory pathogens. - New Asthma Medicine Targeting Vulnerable Inner-City Children Tested By : Respiratory News
UT Southwestern Medical Center is one of a handful of top research institutions evaluating a promising new medication researchers hope can reduce the severity and frequency of asthma attacks in inner-city children, a population known to have a high prevalence of severe asthma. - New CPT Code Awarded, For Asthma Tests Performed With NIOX(R) Nitric Oxide Monitoring System By : Respiratory News
The initial step in establishing a physician reimbursement rate for the measurement of exhaled nitric oxide will go into effect in January 2007 with the awarding of a new Current Procedural Terminology (CPT) Category One code, CPT 95012, by the American Medical Association, Aerocrine Inc. announced today. - New GINA Guidelines Provide Supportive Statements For Symbicort SMART(reg) By : Respiratory News
The Global Initiative for Asthma (GINA) Scientific Committee has announced the release of an updated version of their international treatment guidelines (Global Strategy for Asthma Management and Prevention) and with them a change in the emphasis as to the recommended treatment approach for asthma.(1) - New Recommendations For The Diagnosis Of Pulmonary Embolism By : Respiratory News
Diagnosis of Pulmonary Embolism (PE) is a challenging process. Because PE is only present in about one-third of those in whom it is suspected, the diagnosis must be confirmed or excluded by further testing. - New Research Validates A Lower Dose Of Ciclesonide Is As Effective As Fluticasone Propionate By : Respiratory News
New efficacy data was presented for the first time at the 16th Annual European Respiratory Society (ERS) Congress confirming that a lower dose, or "stepping-down" to ciclesonide (Alvesco(R)), a once-daily, novel, inhaled corticosteroid (ICS) therapy for the treatment of asthma, is an equally effective maintenance treatment as twice-daily fluticasone propionate, another available asthma therapy. - New Standard Certifies Pillows As 'Asthma Friendly' By : Respiratory News
A new certification standard has been launched this holiday season to help people with asthma and allergies find pillows that are more suitable for them. The Asthma and Allergy Foundation of America (AAFA) reports that pillows and other bedding can be home to millions of dust mites and other allergens that cause asthma symptoms. - New Study Demonstrates Rapid Speed Of Onset With Budesonide/formoterol In COPD By : Respiratory News
New data from a study investigating the onset of action with respect to airway dilatation in budesonide/formoterol (Symbicort®), salmeterol/fluticasone (SeretideT), salbutamol and placebo were announced today at the European Respiratory Society 2006 Annual Congress (ERS)1. The data show that budesonide/formoterol has an onset of action that is similar to that of salbutamol and faster than that of salmeterol/fluticasone in patients with COPD. - New Surgery For Asthma Improves Symptoms By : Respiratory News
A new surgical procedure that reduces the amount of a person's airway smooth muscle has the potential to decrease asthma symptoms caused by bronchoconstricition, according to a new study. - New Test Developed For Tuberculosis Is Faster And More Accurate By : Respiratory News
Researchers from the Johns Hopkins Bloomberg School of Public Health, the Imperial College London, Universidad Peruana Cayetano Heredia, in Lima, Peru, and other institutions have developed a simple and rapid new tuberculosis (TB) test. The test, called microscopic-observation drug-susceptibility or MODS, is more sensitive, faster and cheaper to perform than current culture-based tests. The study is published in the October 12, 2006, issue of the New England Journal of Medicine. - New Treatment Approach Holds Promise For Children Infected By Dangerous Respiratory Virus By : Respiratory News
When a child under the age of 2 contracts a respiratory tract infection requiring hospitalization, odds are that the cause is respiratory syncytial virus (RSV). - NHLBI And CMS Launch Large Study Of Home Oxygen Therapy For COPD By : Respiratory News
The National Heart, Lung, and Blood Institute (NHLBI), one of the National Institutes of Health (NIH), and the Centers for Medicare & Medicaid Services (CMS) is launching the largest randomized clinical trial of the effectiveness and safety of long-term, home oxygen therapy for COPD (chronic obstructive pulmonary disease). The six-year, $28 million project will study patients with moderate disease. - Novartis And Schering-Plough Collaboration To Develop Novel Once-daily Combination Therapy ForAsthma By : Respiratory News
Novartis has entered into a global collaboration with Schering-Plough Corporation to develop and commercialize a novel once-daily inhaled fixed-dose combination therapy for the treatment of asthma and chronic obstructive pulmonary disease (COPD), two of the world's most prevalent and urgent respiratory diseases. - Numax(R) Achieves Primary Endpoint In Preliminary Analysis Of Data From Comparative Phase 3 Trial By : Respiratory News
MedImmune, Inc. (Nasdaq: MEDI) today announced preliminary results from a Phase 3 pivotal study showing that Numax met its primary endpoint of non-inferiority by reducing the incidence of hospitalizations caused by respiratory syncytial virus (RSV) in infants at high risk for serious RSV disease by 26 percent when compared to Synagis(R) (palivizumab). - Nutritional Applications That Help Fight Against Asthma By : Aaron Stanlich
Asthma diagnoses have increased in today's society over the last 40 years. The causes can vary, but there are some excellent nutritional elements that can help combat asthma.
|
